Updates are available Correction dated 2021-03-15
Click to view Correction: https://doi.org/10.1186/s12931-021-01678-z
-
Authors
Pison, Christophe http://orcid.org/0000-0002-2152-6461
Shah, Pallav L.
Slebos, Dirk-Jan
Ninane, Vincent
Janssens, Wim
Perez, Thierry
Kessler, Romain
Deslee, Gaetan
Garner, Justin L.
Hartman, Jorine E.
Degano, Bruno
Mayr, Anna
Mayse, Martin
Peterson, Alexander D.
Valipour, Arschang
-
Funding
Funding for this research was provided by:
Nuvaira, Inc
- License Information
-
More Information
Article History
Received: 12 December 2020
Accepted: 11 February 2021
First Online: 19 February 2021
Change Date: 15 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12931-021-01678-z
Ethics approval and consent to participate
: Subjects who participated in the AIRFLOW 1 clinical trial have given their informed consent to participate in this trial. The study protocol was approved by each research institutions committee on human research, see Ref. [CitationRef removed].
: The authors do not plan to share individual deidentified participant data.
: The AIRFLOW-1 clinical trial was funded by Nuvaira, Inc., Minneapolis, MN, USA. PLS and DJS are investigators and advisors to Nuvaira, Inc. ADP and MM are employees of Nuvaira, Inc. CP, VN, WJ, TP, RK, GD, JLG, JEH, BD, AM, AV have nothing to disclose in relation to this work.
